Jamie Sullivan is a pharmacist who is specialized in Pediatrics in Kansas City, Missouri. Patients can reach her at 2401 Gillham Rd, Kansas City or contact her on 816-234-5000. Active license number of Jamie Sullivan is 2021029642 for Pediatrics in Missouri. Jamie Sullivan is a licensed pharmacist who has demonstrated specialized knowledge and skill in the delivery of patient care services by pharmacists that ensures the safe and effective use of medications for all children from neonates through adolescents.
Complete Profile:
Jamie Sullivan speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Jamie Sullivan
Specialization:
Pediatrics
Credentials:
PHARMD
Gender:
Female
Location:
2401 Gillham Rd, Kansas City, Missouri, 64108-4619
Phone:
816-234-5000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Jamie Sullivan are as mentioned below.
NPI Number:
1417688458
NPI Enumeration Date:
21 Jun, 2022
NPI Last Update On:
21 Jun, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jamie Sullivan are as mentioned below.
Specialization
License Number
State
Status
Pediatrics
2021029642
Missouri
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1770 Diamond Pkwy Apt 408, North Kansas City, Missouri
Zip:
64116-4355
Phone Number:
--
Fax Number:
--
Patients can reach Jamie Sullivan at 2401 Gillham Rd, Kansas City, Missouri or can call on phone at 816-234-5000.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.